What's in Mycovia Pharmaceuticals Inc.'s pipeline?

Mycovia Pharmaceuticals Inc. has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Mycovia Pharmaceuticals Inc.'s portfolio?

Top competitors by shared drug class: Dong-A ST Co., Ltd., Elion Therapeutics, Inc., Hadassah Medical Organization, Hatem AbuHashim, Janssen Pharmaceutical K.K..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/mycovia-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Mycovia Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mycovia Pharmaceuticals Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Oteseconazole (VT-1161)	Oteseconazole (VT-1161)	phase 3	Azole antifungal	Fungal lanosterol 14α-demethylase (CYP51)	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Dong-A ST Co., Ltd. · 1 shared drug class
Elion Therapeutics, Inc. · 1 shared drug class
Hadassah Medical Organization · 1 shared drug class
Hatem AbuHashim · 1 shared drug class
Janssen Pharmaceutical K.K. · 1 shared drug class
Jiangsu Aosaikang Pharmaceutical Co., Ltd. · 1 shared drug class
Military Hospital of Tunis · 1 shared drug class
Nuvation Bio Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Mycovia Pharmaceuticals Inc.:

Cite this brief

Drug Landscape (2026). Mycovia Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/mycovia-pharmaceuticals-inc. Accessed 2026-05-17.